Amarin (AMRN) Reports Significant Additional Data from Vascepa Phase 3 ANCHOR
Tweet Send to a Friend
Amarin Corporation plc (Nasdaq: AMRN) presented additional data on Vascepa (icosapent ethyl) and its effect on lipoprotein particle concentration from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE